|
NCI Extramural Support
|
Extramural Support
|
$42,000
|
$42,000
|
NA
|
NCI (NCI)
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-04
|
$234,166
|
$11,708
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$192,324
|
Alavanja
|
DCEG (NCI)
|
|
Signals for Commitment to Radiation Induces Apaptosis
|
5R01CA081504-09
|
$217,607
|
$217,607
|
Almasan, Alexandru
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Host-Tumor Cell Interactions in Myeloma:
|
5P01CA078378-10
|
$2,008,736
|
$2,008,736
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Specialized Program of Research Excellence in Myeloma
|
5P50CA100707-05
|
$2,136,145
|
$2,136,145
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Role of Cytokines in Myeloma Pathogenesis
|
5R01CA050947-16
|
$283,743
|
$283,743
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$7,705
|
Anderson
|
DCEG (NCI)
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$6,434
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
3U10CA045808-21S1
|
$170,000
|
$1,700
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$18,606
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-33
|
$413,938
|
$20,697
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA052667-17
|
$484,826
|
$4,848
|
BAEZ, LUIS
|
SAN JUAN CITY HOSPITAL
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
$5,104
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
$860
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Interim SWOG Committee Renewals (Breast, Head & Neck, Leukemia)
|
3U10CA032102-28S1
|
$187,055
|
$3,741
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
$3,192
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
$6,324
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$188,479
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-03
|
$999,441
|
$99,944
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-06
|
$978,697
|
$195,739
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-13
|
$3,499,541
|
$3,499,541
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$10,031
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$4,631
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$2,527
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$151,292
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$13,870
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Evaluation of novel cytotoxic compounds for immunoconjugates
|
1R43CA128322-01
|
$155,103
|
$77,552
|
BELL, STANLEY
|
ONCONOVA THERAPEUTICS, INC.
|
|
Research on Adverse Drug Events and Reports: Novel Multiple Myeloma Drugs
|
1R01CA125077-01A1
|
$496,470
|
$496,470
|
Bennett, Charles
|
NORTHWESTERN UNIVERSITY
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-32
|
$456,370
|
$22,819
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$1,379
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$2,323
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$115,265
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
$4,589
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
Z01 BC 010698
|
$244,217
|
$24,422
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
Z01 SC 010365
|
$244,217
|
$24,422
|
Bishop, Michael
|
CCR (NCI)
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-10
|
$434,962
|
$13,049
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,250,284
|
$125,028
|
Blumberg, Peter
|
CCR (NCI)
|
|
Morehouse School of Med/Tuskegee Univ/Univ./ of Alabama Cancer Center Partnership
|
2U54CA118638-02
|
$927,843
|
$185,569
|
BLUMENTHAL, DANIEL
|
MOREHOUSE SCHOOL OF MEDICINE
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
1R01CA118880-01A1
|
$259,431
|
$85,612
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Therapeutic and Diagnostic Factors as Related to Cancer Risk
|
Z01 CP010128
|
$211,781
|
$7
|
Brinton
|
DCEG (NCI)
|
|
Studies of Rare Cancers
|
Z01 CP010158
|
$567,045
|
$2,325
|
Brinton
|
DCEG (NCI)
|
|
Southwest Oncology Group
|
2U10CA004919-48
|
$192,303
|
$3,846
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
3U10CA004919-48S1
|
$25,000
|
$500
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-05
|
$994,868
|
$29,846
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
2P30CA023100-23
|
$3,966,000
|
$79,320
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S1
|
$115,875
|
$2,318
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-23S2
|
$92,700
|
$1,854
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
Total relevant funding to Multiple Myeloma for this search: $32,251,699
|